ALNITAK PHARMACEUTICALS
village jagaat khana, Nalagarh, Himachal Pradesh 174101
|
||||||||
PACK SIZE AS PER SCHEDULE P-1 THE DRUG & COSMETICS RULES 1945 | ||||||||
Sr. No. | Dosage Form | Generic Name | Composition | Spc. | Qty. | Unit | Marketed By | Approved or Rejected |
01. | Tablets | Levofloxacin Tablets I.P. | Each film coated tablet contains: | Self | Approved -05.08.15 | ||||
Levofloxacin hemihydrate
eq. to Levofloxacin |
I.P. | 500 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
02. | Tablets | Levofloxacin Tablets I.P. | Each film coated tablet contains: | Self | Approved -05.08.15 | ||||
Levofloxacin hemihydrate
eq.to Levofloxacin |
I.P. | 750 | mg | ||||||
Excipients | q.s. | ||||||||
Approved Colour used | |||||||||
03. | Tablets | Ferrous Ascorbate,Folic acid and Zinc Sulphate Monohydrate Tablets | Each Film coated tablet contains: | Self | Approved -05.08.15 | ||||
Ferrous ascorbate
eq. to elemental iron |
100 | mg | |||||||
Folic Acid | I.P. | 1.5 | mg | ||||||
Zinc Sulphate Monohydrate
eq. to elemental zinc |
I.P. | 22.5 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
04. | Tablets | Ofloxacin and Ornidazole Tablets | Each film coated tablet contains: | Self | Approved -05.08.15 | ||||
Ofloxacin | I.P. | 200 | mg | ||||||
Ornidazole | I.P. | 500 | mg | ||||||
Excipients | q.s. | ||||||||
Approved Colour used | |||||||||
05. | Tablets | Rabeprazole Gastro-resistant Tablets I.P. | Each enteric coated tablet contains: | Self | Approved -05.08.15 | ||||
Rabeprazole Sodium | I.P. | 20 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
06. | Tablets | Deflazacort Tablets | Each uncoated tablet contains: | Self | Approved -05.08.15 | ||||
Deflazacort | 6 | mg | |||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
07. | Tablets | Deflazacort Tablets | Each uncoated tablet contains: | Self |
Approved -05.08.15 |
||||
Deflazacort | 30 | mg | |||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
08. | Tablets | Azithromycin Tablets I.P.
|
Each film coated tablet contains : | Self | Approved -05.08.15 | ||||
Azithromycin Dihydrate
eq.to Azithromycin anhydrous |
I.P. | 250 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
09. | Tablets | Azithromycin Tablets I.P.
|
Each film coated tablet contains : | Self | Approved -05.08.15 | ||||
Azithromycin Dihydrate
eq.to Azithromycin anhydrous |
I.P. | 500 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
10. | Liquid Orals | Albendazole Oral Suspension I.P. | Each 5ml contains: | Self | Approved -05.08.15 | ||||
Albendazole | I.P. | 200 | mg | ||||||
Excipients | q.s. | ||||||||
In a flavoured base | q.s. | ||||||||
Approved Colour used | |||||||||
11. | Liquid Orals | Magaldrate and Simethicone Oral Suspension U.S.P. | Each 5ml contains: | Self | Approved -05.08.15
|
||||||
Magaldrate (Anhydrous) | I.P. | 400 | mg | ||||||||
Simethicone | I.P. | 60 | mg | ||||||||
In a palatable suspension base | |||||||||||
Excipients | q.s. | ||||||||||
Approved Colour used | |||||||||||
12. | Liquid Orals | Ferrous Ascorbate and Folic Acid Suspension | Each 5ml contains: | Self | Approved -05.08.15 | ||||||
Ferrous Ascorbate
eq.to elemental iron |
I.P. | 30 | mg | ||||||||
Folic Acid | I.P. | 550 | mcg | ||||||||
Excipients | q.s. | ||||||||||
Flavoured syrupy base | q.s. | ||||||||||
Colour: Approved colour used | |||||||||||
13. | Liquid Orals | Terbutaline Sulphate,Ambroxol hydrochloride, Guaiphenesin and Menthol Syrup | Each 5ml contains: | Self | Approved -05.08.15 | ||||||
Terbutaline Sulphate | I.P. | 1.25 | mg | ||||||||
Ambroxol hydrochloride | I.P. | 15 | mg | ||||||||
Guaiphenesin | I.P. | 50 | mg | ||||||||
Menthol | I.P. | 2.5 | mg | ||||||||
Excipients | q.s. | ||||||||||
Flavoured syrupy base | q.s. | ||||||||||
Colour: Approved colour used | |||||||||||
14. | Liquid Orals | Dried Aluminium Hydroxide Gel,Magnesium Hydroxide and Activated Dimethicone Suspension | Each 5ml contains: | Self | Approved -05.08.15 | ||||||
Dried Aluminium Hydroxide Gel
eq.to Aluminium Hydroxide |
I.P. | 250 | mg | ||||||||
Magnesium Hydroxide | I.P. | 250 | mg | ||||||||
Activated Dimethicone | I.P. | 50 | mg | ||||||||
Flavoured Sorbitol Solution (70%) {Non-Crystallizing} | I.P. | 1.25 | gm | ||||||||
Purified Water | I.P. | q.s. | |||||||||
Excipients | q.s. | ||||||||||
Colour: Approved colour used | |||||||||||
15. | Capsules | Omeprazole Gastro-resistant Capsules I.P. | Each hard gelatin capsule contains: | Self | Approved -05.08.15 | ||||||
Omeprazole (as enteric coated granules) | I.P. | 20 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used in capsule shells | |||||||||||
16. | Capsules | Omeprazole and Domperidone Capsules | Each hard gelatin capsule contains: | Self | Approved -05.08.15 | ||||||
Omeprazole (as enteric coated granules) | I.P. | 20 | mg | ||||||||
Domepridone | I.P. | 10 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used in capsule shells | |||||||||||
17. | Capsules | Rabeprazole and Domperidone Capsules | Each hard gelatin capsule contains: | Self | Approved -05.08.15 | ||||||
Rabeprazole Sodium
(as enteric coated pellets) |
I.P. | 20 | mg | ||||||||
Domepridone
(as sustained released pellets) |
I.P. | 30 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used in empty capsule shells | |||||||||||
18. | Capsules | Pantoprazole and Domperidone Capsules | Each hard gelatin capsule contains: | Self | Approved -05.08.15 | ||||||
Pantoprazole Sodium
eq.to Pantoprazole (as enteric coated pellets) |
I.P. |
40 |
mg |
||||||||
Domepridone
(as sustained released pellets) |
I.P. | 30 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used in empty capsule shells | |||||||||||
19. | Capsules | Fluconazole Capsules I.P. | Each hard gelatin capsule contains: | Self | Approved -05.08.15 | ||||||
Fluconazole | I.P. | 150 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used in capsule shells | |||||||||||
20. | Capsules | Pantoprazole and Itopride Hydrochloride Capsules | Each hard gelatin capsule contains: | Self | Approved -05.08.15 | ||||||
Pantoprazole Sodium
eq.to Pantoprazole (as enteric coated pellets) |
I.P. |
40 |
mg |
||||||||
Itopride Hydrochloride
(as sustained released pellets) |
150 | mg | |||||||||
Excipients | q.s. | ||||||||||
Approved colour used in empty capsule shells | |||||||||||
21. | Capsules | Rabeprazole and Levosulpride Capsules | Each hard gelatin capsule contains: | Self | Approved -05.08.15 | ||||||
Rabeprazole Sodium
(as enteric coated pellets) |
I.P. | 20 | mg | ||||||||
Levosulpride
(as sustained released pellets) |
75 | mg | |||||||||
Excipients | q.s. | ||||||||||
Approved colour used in empty capsule shells | |||||||||||
22. | Tablets | Roxithromycin Tablets I.P. | Each film coated tablet contains : | Self | Approved -20.08.15 | ||||||
Roxithromycin | I.P. | 150 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used | |||||||||||
23. | Tablets | Montelukast and Levocetirizine Tablets | Each film coated tablet contains : | Self | Approved -20.08.15 | ||||||
Montelukast Sodium
eq.to Montelukast |
I.P. |
10 |
mg |
||||||||
Levocetirizine hydrochloride | I.P. | 5 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used | |||||||||||
24. | Tablets | Paracetamol and Nimesulide Tablets
(Not to be used for children below 12 years of age)
|
Each uncoated tablet contains : | Self | Approved -20.08.15 | ||||||
Paracetamol | I.P. | 325 | mg | ||||||||
Nimesulide | B.P. | 100 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used | |||||||||||
25. | Tablets | Pantoprazole and Domperidone Tablets | Each enteric coated tablet contains: | Self | Approved -20.08.15 | ||||||
Pantoprazole Sodium
eq.to Pantoprazole |
I.P. |
40 |
mg |
||||||||
Domperidone | I.P. | 10 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used | |||||||||||
26. | Tablets | Ondansetron Orally
Disintegrating Tablets I.P. |
Each uncoated tablet contains: | Self | Approved -20.08.15 | ||||||
Ondansetron hydrochloride
eq. to Ondansetron |
I.P. | 4 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used | |||||||||||
27.
|
Tablets | Diclofenac Sodium and Paracetamol Tablets
(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each uncoated tablet contains : | Self | Approved -20.08.15 | ||||
Diclofenac Sodium | I.P. | 50 | mg | ||||||
Paracetamol | I.P. | 325 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
28. | Tablets | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains: | Self | Approved -20.08.15 | ||||
Lornoxicam | 8 | mg | |||||||
Paracetamol | I.P. | 325 | mg | ||||||
Excipients | q.s. | ||||||||
Approved Colour used | |||||||||
29. | Tablets | Etoricoxib Tablets I.P. | Each film coated tablet contains: | Self | Approved -20.08.15 | ||||
Etoricoxib | I.P. | 90 | mg | ||||||
Excipients | q.s. | ||||||||
Approved Colour used | |||||||||
30. | Tablets | Etoricoxib Tablets I.P. | Each film coated tablet contains: | Self | Approved -20.08.15 | ||||
Etoricoxib | I.P. | 120 | mg | ||||||
Excipients | q.s. | ||||||||
Approved Colour used | |||||||||
31. | Tablets | Etoricoxib and Thiocolchicoside Tablets | Each film coated tablet contains: | Self | Approved -20.08.15 | ||||
Etoricoxib | I.P. | 60 | mg | ||||||
Thiocolchicoside | I.P. | 4 | mg | ||||||
Excipients | |||||||||
Approved Colour used | |||||||||
32. | Tablets | Desloratadine and Montelukast Tablets | Each film coated tablet contains: | Self | Approved -20.08.15 | ||||
Desloratadine | 5 | mg | |||||||
Montelukast Sodium
eq. to Montelukast |
I.P. |
10 |
mg |
||||||
Excipients | |||||||||
Approved Colour used | |||||||||
33. | Tablets | Aceclofenac and Paracetamol Tablets | Each uncoated tablet contains: | Self | Approved -20.08.15 | ||||
Aceclofenac | I.P. | 100 | mg | ||||||
Paracetamol | I.P. | 325 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
34. | Tablets | Ofloxacin Tablets I.P. | Each film coated tablet contains: | Self | Approved -20.08.15 | ||||
Ofloxacin | I.P. | 200 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
35. | Tablets | Pantoprazole Gastro-resistant Tablets I.P. | Each enteric-coated tablet contains: | Self | Approved -20.08.15 | |||
Pantoprazole Sodium
eq.to Pantoprazole |
I.P. | 40 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used | ||||||||
36. | Tablets | Ciprofloxacin Tablets I.P. | Each film coated tablet contains: | Self | Approved -20.08.15 | |||
Ciprofloxacin Hydrochloride
eq.to Ciprofloxacin |
I.P. | 250 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
37. | Tablets | Ciprofloxacin Tablets I.P. | Each film coated tablet contains: | Self | Approved -20.08.15 | |||
Ciprofloxacin Hydrochloride
eq.to Ciprofloxacin |
I.P. | 500 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
38. | Tablets | Albendazole Tablets I.P. | Each uncoated chewable tablet contains: | Self | Approved -20.08.15 | |||
Albendazole | I.P. | 400 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used | ||||||||
39. | Tablets | Levocetirizine Dihydrochloride Tablets I.P. | Each uncoated tablet contains: | Self | Approved -20.08.15 | |||
Levocetirizine Dihydrochloride | I.P. | 5 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
40.
|
Tablets | Fexofenadine and Montelukast Tablets | Each chewable film coated tablet contains : | Self | Approved -03.09.15 | |||
Fexofenadine Hydrochloride | I.P. | 120 | mg | |||||
Montelukast Sodium
eq.to Montelukast |
I.P. |
10 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
41. | Tablets | Aceclofenac Sustained Released Tablets 200mg | Each uncoated sustained released tablet contains : | Self | Approved -03.09.15 | |||
Aceclofenac | I.P. | 200 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
42. | Liquid Orals | Paracetamol Paediatric Oral Suspension I.P. | Each 5ml contains : | Self | Approved -03.09.15 | |||
Paracetamol | I.P. | 125 | mg | |||||
Excipients | q.s. | |||||||
Flavoured syrupy base | q.s. | |||||||
Approved colour used | ||||||||
43. | Liquid Orals | Paracetamol Paediatric Oral Suspension I.P. | Each 5ml contains : | Self | Approved -03.09.15 | |||
Paracetamol | I.P. | 250 | mg | |||||
Excipients | q.s. | |||||||
Flavoured syrupy base | q.s. | |||||||
Approved colour used | ||||||||
44. | Liquid Orals | Ondansetron Oral Solution I.P. | Each 5ml contains : | Self | Approved -03.09.15 | |||
Ondansetron Hydrochloride
eq.to Ondansetron |
I.P. |
2 |
mg |
|||||
Excipients | q.s. | |||||||
Flavoured syrupy base | q.s. | |||||||
Approved colour used | ||||||||
45. | Tablets | Fluconazole Tablets I.P. | Each uncoated tablet contains : | Self | Approved -03.09.15 | |||
Fluconazole | I.P. | 150 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
46. | Tablets | Fluconazole Tablets I.P. | Each uncoated tablet contains : | Self | Approved -03.09.15 | |||
Fluconazole | I.P. | 200 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
47. | Tablets | Levofloxacin Tablets I.P. | Each film coated tablet contains : | Self | Approved -03.09.15 | |||
Levofloxacin Hemihydrate
eq.to Levofloxacin |
I.P. |
250 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
48. | Tablets | Ondansetron Orally Disintegrating Tablets I.P. | Each uncoated tablet contains : | Self | Approved -03.09.15 | |||
Ondansetron Hydrochloride
eq.to Ondansetron |
I.P. |
8 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
49. | Tablets | Cetirizine Hydrochloride Tablets I.P. | Each uncoated tablet contains : | Self | Approved -03.09.15 | |||
Cetirizine Hydrochloride | I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used |
50. | Tablets | Nimesulide Tablets | Each uncoated tablet contains : | Self | Approved -03.09.15 | |||
Nimesulide | B.P. | 100 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
51. | Tablets | Doxofylline Tablets I.P. | Each uncoated tablet contains : | Self | Approved -03.09.15
|
|||
Doxofylline | I.P. | 400 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
52. | Liquid Orals | Ofloxacin Oral Suspension I.P. | Each 5ml contains : | Self | Approved -03.09.15 | |||
Ofloxacin | I.P. | 50 | mg | |||||
Excipients | q.s. | |||||||
Flavoured syrupy base | q.s. | |||||||
Approved colour used | ||||||||
53. | Tablets | Albendazole and Ivermectin Tablets | Each uncoated tablet contains : | Self | Approved -03.09.15 | |||
Albendazole | I.P. | 400 | mg | |||||
Ivermectin | I.P. | 6 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
54. | Tablets | Levocetirizine Hydrochloride and Montelukast Tablets | Each film coated tablet contains : | Self | Approved -03.09.15 | |||
Levocetirizine Hydrochloride | I.P. | 2.5 | mg | |||||
Montelukast Sodium
eq.to Montelukast |
I.P. | 4 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
55. | Tablets | Ofloxacin and Nitazoxanide Tablets | Each film coated tablet contains : | Self | Approved -03.09.15 | |||
Ofloxacin | I.P. | 200 | mg | |||||
Nitazoxanide | 500 | mg | ||||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
56. | Capsules | Omeprazole and Domperidone Capsules | Each hard gelatin capsule contains : | Self | Approved -03.09.15 | |||
Omeprazole (as enteric coated granules) | I.P. | 20 | mg | |||||
Domperidone (as sustained released pellets) | I.P. | 30 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used in empty capsule shells | ||||||||
57. | Capsules | Esomeprazole and Domperidone Capsules | Each hard gelatin capsule contains : | Self | Approved -03.09.15 | |||
Esomeprazole Magnesium Trihydrate
eq. to Esomeprazole (as enteric coated pellets) |
I.P. |
20 |
mg |
|||||
Domperidone (as sustained released pellets) | I.P. | 30 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used in empty capsule shells | ||||||||
58. | Liquid Orals | Azithromycin Oral Suspension I.P. | Each 5ml contains : | Self | Approved -03.09.15 | |||
Azithromycin Dihydrate
eq.to anhydrous Azithromycin |
I.P. |
200 |
mg |
|||||
Excipients | q.s. | |||||||
Flavoured syrupy base | q.s. | |||||||
Approved colour used | ||||||||
59.
|
Liquid Orals | Phenylephrine HCl,Paracetamol, Chlorpheniramine Maleate,Sodium Citrate and Menthol Syrup | Each 5ml contains : | Self | Approved -03.09.15 | |||
Phenylephrine HCl | I.P. | 5 | mg | |||||
Paracetamol | I.P. | 125 | mg | |||||
Chlorpheniramine Maleate | I.P. | 0.5 | mg | |||||
Sodium Citrate | I.P. | 60 | mg | |||||
Menthol | I.P. | 1 | mg | |||||
Excipients | ||||||||
Flavoured syrupy base | q.s. | |||||||
Approved colour used | ||||||||
60. | Tablets | Glucosamine,Methyl sulphonylmethane and Diacerein Tablets | Each film coated tablet contains : | Self | Approved -03.09.15 | |||
Glucosamine Sulphate Potassium Chloride
eq.to Glucosamine |
USP | 750
446 |
mg
mg |
|||||
Methylsulphonylmethane | USP | 250 | mg | |||||
Diacerein | I.P. | 50 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
61. | Tablets | Ferrous Ascorbate and Folic Acid Tablets | Each film coated tablet contains : | Self | Approved -03.09.15 | |||
Ferrous Ascorbate
eq.to elemental iron |
I.P. |
100 |
mg |
|||||
Folic Acid | I.P. | 1.5 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used |
62. | Capsules | Pregabalin and Methylcobalamin Capsules | Each hard gelatin capsule contains : | Self | Approved -03.09.15 | |||
Pregabalin | I.P. | 75 | mg | |||||
Methylcobalamin | J.P. | 750 | mcg | |||||
Excipients | q.s. | |||||||
Approved colour used in empty capsule shells | ||||||||
Appropriate overages of vitamin added to compensate loss on storage. | ||||||||
63. | Tablets | Diclofenac Potassium and Serratiopeptidase Tablets | Each enteric coated tablet contains : | Self | Approved -03.09.15 | |||
Diclofenac Potassium | B.P. | 50 | mg | |||||
Serratiopeptidase
(as enteric coated granules eq.to enzymatic activity 20,000 units) |
I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used | ||||||||
64. | Tablets | Fexofenadine Hydrochloride Tablets I.P. | Each film coated tablet contains : | Self | Approved -24.12.15 | |||
Fexofenadine Hydrochloride | I.P. | 120 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
65. | Tablets | Fexofenadine Hydrochloride Tablets I.P. | Each film coated tablet contains : | Self | Approved -24.12.15 | |||
Fexofenadine Hydrochloride | I.P. | 180 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
66. | Tablets | Atorvastatin Tablets I.P. | Each film-coated tablet contains : | Self | Approved -24.12.15 | |||
Atorvastatin Calcium
eq.to Atorvastatin |
I.P. |
10 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
67. | Tablets | Atorvastatin Tablets I.P. | Each film-coated tablet contains : | Self | Approved -24.12.15 | |||
Atorvastatin Calcium
eq.to Atorvastatin |
I.P. |
20 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
68. | Tablets | Atorvastatin Tablets I.P. | Each film-coated tablet contains : | Self | Approved -24.12.15 | |||
Atorvastatin Calcium
eq.to Atorvastatin |
I.P. |
40 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
69. | Tablets | Atenolol Tablets I.P. | Each uncoated tablet contains : | Self | Approved -24.12.15 | |||
Atenolol | I.P. | 50 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
70. | Tablets | Atenolol Tablets I.P. | Each uncoated tablet contains : | Self | Approved -24.12.15 | |||
Atenolol | I.P. | 100 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
71. | Tablets | Glimepiride Tablets I.P. | Each uncoated tablet contains : | Self | Approved -24.12.15 | |||
Glimepiride | I.P. | 2 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
72. | Tablets | Sildenafil Citrate Tablets I.P. | Each film-coated tablet contains : | Self | Approved -24.12.15 | |||
Sildenafil Citrate
eq.to Sildenafil |
I.P. |
50 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
73. | Tablets | Sildenafil Citrate Tablets I.P. | Each film-coated tablet contains : | Self | Approved -24.12.15 | |||
Sildenafil Citrate
eq.to Sildenafil |
I.P. |
100 |
mg |
|||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
74. | Tablets | Telmisartan and Amlodipine Besilate Tablets | Each uncoated tablet contains : | Self | Approved -24.12.15 | |||
Telmisartan | I.P. | 80 | mg | |||||
Amlodipine Besilate
eq.to Amlodipine |
I.P. | 5 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used | ||||||||
75. | Tablets | Paracetamol and Tramadol Hydrochloride Tablets | Each film-coated tablet contains : | Self | Approved -24.12.15 | |||
Paracetamol | I.P. | 325 | mg | |||||
Tramadol Hydrochloride | I.P. | 37.5 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used |
76. | Tablets | Montelukast and Levocetirizine Hydrochloride Tablets | Each uncoated Dispersible tablet contains : | Self | Approved -24.12.15 | |||||
Montelukast Sodium
eq.to Montelukast |
I.P. |
5 |
mg |
|||||||
Levocetirizine Hydrochloride | I.P. | 2.5 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
77. | Liquid Orals | Ambroxol HCl,Levosalbutamol Sulphate and Guaiphenesin Syrup | Each 5ml contains : | Self | Approved -24.12.15 | |||||
Ambroxol Hydrochloride | I.P. | 30 | mg | |||||||
Levosalbutamol Sulphate
eq.to Levosalbutamol |
I.P. | 1 | mg | |||||||
Guaiphenesin | I.P. | 50 | mg | |||||||
Excipients | q.s. | |||||||||
Flavoured syrupy base | q.s. | |||||||||
Approved colour used | ||||||||||
78. | Liquid Orals | Levocetirizine Hydrochloride Syrup | Each 5ml contains : | Self | Approved -24.12.15 | |||||
Levocetirizine Hydrochloride | I.P. | 2.5 | mg | |||||||
Excipients | q.s. | |||||||||
In a Flavoured syrupy base | q.s. | |||||||||
Approved colour used | ||||||||||
79. | Liquid Orals | Dried Aluminium Hydroxide,Magnesium Hydroxide,Simethicone and Oxetacaine Syrup | Each 5ml contains : | Self | Approved -24.12.15 | |||||
Dried Aluminium Hydroxide Gel
eq.to Aluminium Hydroxide |
I.P. |
600 |
mg |
|||||||
Magnesium Hydroxide | I.P. | 300 | mg | |||||||
Simethicone | I.P. | 25 | mg | |||||||
Oxetacaine | B.P. | 10 | mg | |||||||
Purified Water | I.P. | q.s. | ||||||||
Excipients | q.s. | |||||||||
Flavoured syrupy base | q.s. | |||||||||
Approved colour used | ||||||||||
80. | Liquid Orals | Deflazacort Oral Suspension | Each 5ml contains: | Self | Approved -16.02.16 | |||||
Deflazacort | 6 | mg | ||||||||
Flavoured Syrupy base | q.s. | |||||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
81. | Tablets | Duloxetine Hydrochloride Tablets | Each film coated tablet contains: | Self | Approved -16.02.16 | |||||
Duloxetine Hydrochloride
eq.to Duloxetine |
USP | 20 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
82. | Tablets | Etoricoxib and Paracetamol Tablets | Each film coated tablet contains: | Self | Approved -16.02.16 | |||||
Etoricoxib | I.P. | 60 | mg | |||||||
Paracetamol | I.P. | 325 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
83. | Tablets | Betahistine Hydrochloride Tablets I.P. | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Betahistine Hydrochloride | I.P. | 16 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
84. | Tablets | Tranexamic Acid and Mefenamic Acid Tablets | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Tranexamic Acid | I.P. | 500 | mg | |||||||
Mefenamic Acid | I.P. | 250 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
85. | Capsules | Rebeprazole and Itopride Hydrochloride Capsules | Each hard gelatin capsules contains : | Self | Approved -16.02.16 | |||||
Rebeprazole Sodium
(as enteric coated pellets) |
I.P. | 20 | mg | |||||||
Itopride Hydrochloride
(as sustained released pellets) |
150 | mg | ||||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
86. | Tablets | Artemether and Lumefantrine Tablets | Each uncoated tablet contains : | Self | Approved -16.02.16 | |||||
Artemether | I.P. | 80 | mg | |||||||
Lumefantrine | 480 | mg | ||||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
87. | Tablets | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Lornoxicam | 4 | mg | ||||||||
Paracetamol | I.P. | 325 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
88. | Tablets | Levocetirizine Hydrochloride and Ambroxol Hydrochloride (SR) Tablets | Each uncoated sustained released tablet contains : | Self | Approved -16.02.16 | |||||
Levocetirizine Hydrochloride | I.P. | 5 | mg | |||||||
Ambroxol Hydrochloride (as sustained released) | I.P. | 75 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
89. | Tablets | Aceclofenac and Thiocolchicoside Tablets | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Aceclofenac | I.P. | 100 | mg | |||||||
Thiocolchicoside | I.P. | 8 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
90. | Tablets | Aceclofenac and Thiocolchicoside Tablets | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Aceclofenac | I.P. | 100 | mg | |||||||
Thiocolchicoside | I.P. | 4 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
91. | Tablets | Diacerein and Aceclofenac Tablets | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Diacerein | I.P. | 50 | mg | |||||||
Aceclofenac | I.P. | 100 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
92. | Tablets | Gabapentin and Methylcobalamin Tablets | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Gabapentin | USP | 300 | mg | |||||||
Methylcobalamin | J.P. | 500 | mcg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
93. | Tablets | Paracetamol Tablets I.P. | Each uncoated tablet contains : | Self | Approved -16.02.16 | |||||
Paracetamol | I.P. | 650 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
94. | Tablets | Aceclofenac and Paracetamol Tablets | Each film coated tablet contains : | Self | Approved -16.02.16 | |||||
Aceclofenac | I.P. | 100 | mg | |||||||
Paracetamol | I.P. | 325 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
95. | Tablets | Methylprednisolone Tablets I.P. | Each uncoated tablet contains : | Self | Approved -16.02.16 | |||||
Methylprednisolone | I.P. | 4 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
96 | Tablets | Methylprednisolone Tablets I.P. | Each uncoated tablet contains : | Self | Approved -16.02.16 | |||||
Methylprednisolone | I.P. | 8 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
97. | Tablets | Methylprednisolone Tablets I.P. | Each uncoated tablet contains : | Self | Approved -16.02.16 | |||||
Methylprednisolone | I.P. | 16 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
98. | Tablets | Betamethasone Sodium Phosphate Tablets I.P. | Each uncoated tablet contains : | Self | Approved -16.02.16 | |||||
Betamethasone Sodium Phosphate
eq.to Betamethasone |
I.P. | 0.5 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
99. | Tablets | Paracetamol Tablets I.P. | Each uncoated tablet contains : | Self | Approved -16.02.16 | |||||
Paracetamol | I.P. | 500 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
100 | Tablets | Esomeprazole gastro-resistant Tablets I.P. | Each enteric coated tablet contains : | Self | Approved -16.02.16 | |||||
Esomeprazole Magnesium Trihydrate
eq.to Esomeprazole |
I.P. | 20 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
101 | Capsules | Methylcobalamin, Alpha Lipoic Acid,Thiamine Mononitrate, Pyridoxine HCl and Folic Acid Capsules | Each hard gelatin capsule contains | Self | Approved -20.02.16 | |||||
Methylcobalamin | J.P | 1500 | mcg | |||||||
Alpha Lipoic Acid | I.P. | 100 | mg | |||||||
Thiamine Mononitrate | I.P. | 10 | mg | |||||||
Pyridoxine Hydrochloride | I.P. | 3 | mg | |||||||
Folic Acid | I.P. | 1.5 | mg | |||||||
Excipients | q.s. | |||||||||
Appropriate overages of vitamins are added to compensate loss on storage | ||||||||||
Approved colour used in empty capsule shells | ||||||||||
102 | Liquid Orals | Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate oral emulsion | Each 5ml (1 teaspoonful approx.)contains : | Self | Approved -20.02.16 | ||||||
Sodium Picosulfate | B.P. | 33.3 | mg | ||||||||
Liquid Paraffin | I.P. | 1.25 | ml | ||||||||
Milk of Magnesia | I.P. | 3.75 | ml | ||||||||
Excipients | q.s. | ||||||||||
Indication: For symptomatic treatment of constipation in adults | |||||||||||
Dosage: As directed by the physician | |||||||||||
Approved Colour used | |||||||||||
103 | Capsules | Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules | Each hard gelatin capsule contains | Self | Approved -20.02.16 | ||||||
Methylcobalamin | J.P | 1000 | mcg | ||||||||
Alpha Lipoic Acid | I.P. | 200 | mg | ||||||||
Benfotiamine | 100 | mg | |||||||||
Folic Acid | I.P. | 1.5 | mg | ||||||||
Pyridoxine HCl | I.P. | 3 | mg | ||||||||
Inositol | USP | 100 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved colour used in empty capsule shells | |||||||||||
104 | Tablets | Methylprednisolone Tablets I.P. | Each film coated tablet contains : | Self | Approved-12.04.16 | ||||||
Methylprednisolone | I.P. | 4 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved Colour used | |||||||||||
105 | Tablets | Ranitidine Tablets I.P. | Each film coated tablet contains : | Self | Approved-12.04.16 | ||||||
Ranitidine Hydrochloride
eq.to Ranitidine |
I.P. | 150 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved Colour used | |||||||||||
106 | Tablets | Serratiopeptidase Tablets I.P. | Each enteric coated tablet contains : | Self | Approved-12.04.16 | ||||||
Serratiopeptidase
(as enteric coated granules eq.to enzymatic activity 20000 units) |
I.P. | 10 | mg | ||||||||
Excipients | q.s. | ||||||||||
Approved Colour used | |||||||||||
107 | Liquid Orals | Terbutaline Sulphate,Ambroxol hydrochloride, Guaiphenesin and Menthol Syrup | Each 5ml contains: | Self | Approved-12.04.16 | ||||||
Terbutaline Sulphate | I.P. | 2.5 | mg | ||||||||
Ambroxol hydrochloride | I.P. | 30 | mg | ||||||||
Guaiphenesin | I.P. | 100 | mg | ||||||||
Menthol | I.P. | 2.5 | mg | ||||||||
Excipients | q.s. | ||||||||||
Flavoured syrupy base | q.s. | ||||||||||
Colour: Approved colour used | |||||||||||
108 | Liquid Orals | Ambroxol hydrochloride, Levosalbutamol and Guaiphenesin Syrup | Each 5ml contains: | Self | Approved-12.04.16 | ||||||
Ambroxol hydrochloride | I.P. | 30 | mg | ||||||||
Levosalbutamol | 1 | mg | |||||||||
Guaiphenesin | I.P. | 50 | mg | ||||||||
Excipients | q.s. | ||||||||||
Flavoured syrupy base | q.s. | ||||||||||
Colour: Approved colour used | |||||||||||
109 | Liquid Orals | Cyproheptadine Hydrochloride and Tricholine Citrate Syrup | Each 5ml contains : | Self | Approved-26.04.16. | ||||||
Cyproheptadine Hydrochloride | I.P. | 2 | mg | ||||||||
Tricholine Citrate | 275 | mg | |||||||||
Excipients | q.s. | ||||||||||
Flavoured Syrupy base | q.s. | ||||||||||
Colour: Caramel | I.P. | ||||||||||
110 | Liquid Orals | Aceclofenac and Paracetamol Suspension | Each 5ml contains : | Self | Approved-26.04.16. | ||||||
Aceclofenac | I.P. | 50 | mg | ||||||||
Paracetamol | I.P. | 125 | mg | ||||||||
Excipients | q.s. | ||||||||||
Flavoured Syrupy base | q.s. | ||||||||||
Colour: Tartrazine | |||||||||||
111 | Liquid Orals | Mefenamic Acid and Paracetamol Suspension | Each 5ml contains : | Self | Approved-26.04.16. | ||||||
Mefenamic Acid | I.P. | 50 | mg | ||||||||
Paracetamol | I.P. | 125 | mg | ||||||||
Excipients | q.s. | ||||||||||
Flavoured Syrupy base | q.s. | ||||||||||
Colour: Sunset Yellow FCF | |||||||||||
112 | Liquid Orals | Cyproheptadine Hydrochloride and Tricholine Citrate Syrup | Each 5ml contains : | Self | Approved-26.04.16. | ||||||
Cyproheptadine Hydrochloride | I.P. | 2 | mg | ||||||||
Tricholine Citrate | 275 | mg | |||||||||
Sorbitol Solution 70%
(Non-crystallizing) |
I.P. | 3.575 | gm | ||||||||
Excipients | q.s. | ||||||||||
In a Palatable non syrupy base | q.s. | ||||||||||
Colour: Sunset Yellow FCF | |||||||||||
113 | Liquid Orals | Tricholine Citrate Syrup | Each 10ml contains : | Self | Approved-26.04.16. | ||||
Tricholine Citrate | 0.55 | gm | |||||||
Sorbitol Solution 70%
(Non-crystallizing) |
I.P. | 7.150 | gm | ||||||
Excipients | q.s. | ||||||||
In a Palatable non syrupy base | q.s. | ||||||||
Colour: Approved colour used | |||||||||
114 | Liquid Orals | Diastase and Pepsin syrup | Each 5ml contains : | Self | Approved-26.04.16. | ||||
Diastase (1:1200) | I.P. | 50 | mg | ||||||
Pepsin (1:3000) | I.P. | 10 | mg | ||||||
Excipients | q.s. | ||||||||
Flavoured Palatable base | q.s. | ||||||||
Colour: Approved colour used | |||||||||
Dosage:
Adult: One teaspoonful immediately after the meal. Childern: Half the adult dose. As directed by the physician. |
|||||||||
115 | Liquid Orals | Dicyclomine Hydrochloride and Activated Dimethicone Drops | Each ml contains : | Self | Approved-26.04.16. | ||||
Dicyclomine Hydrochloride | I.P. | 10 | mg | ||||||
Activated Dimethicone | I.P. | 40 | mg | ||||||
Excipients | q.s. | ||||||||
Flavoured Syrupy base | q.s. | ||||||||
Colour: Sunset Yellow FCF | |||||||||
For Paediatric use only | |||||||||
116 | Liquid Orals | Magaldrate and Simethicone Oral Suspension U.S.P. | Each 5ml contains : | Self | Approved-26.04.16. | ||||
Magaldrate (anhydrous) | I.P. | 500 | mg | ||||||
Simethicone | I.P. | 25 | mg | ||||||
Sorbitol Solution 70%
(Non-crystallizing) |
I.P. | ||||||||
Excipients | q.s. | ||||||||
Purified Water | I.P. | q.s. | |||||||
Colour: Sunset Yellow FCF | |||||||||
117 | Liquid Orals | Ibuprofen and Paracetamol Suspension | Each 5ml contains : | Self | Approved-26.04.16. | ||||
Ibuprofen | I.P. | 100 | mg | ||||||
Paracetamol | I.P. | 125 | mg | ||||||
Excipients | q.s. | ||||||||
In a flavoured syrupy base | q.s. | ||||||||
Colour: Sunset Yellow FCF | |||||||||
118 | Tablets | Aceclofenac Sustained Released Tablets 200mg | Each film coated sustained released tablet contains : | Self | Approved-26.04.16. | ||||
Aceclofenac | I.P. | 200 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
119 | Tablets | Drotaverine Hydrochloride and Mefenamic Acid Tablets | Each film coated tablet contains : | Self | Approved-26.04.16. | ||||
Drotaverine Hydrochloride | I.P. | 80 | mg | ||||||
Mefenamic Acid | I.P. | 250 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
120 | Tablets | Ciprofloxacin and Tindazole Tablets | Each film coated tablet contains : | Self | Approved-26.04.16. | ||||
Ciprofloxacin Hydrochloride
eq.to Ciprofloxacin |
I.P. | 500 | mg | ||||||
Tindazole | I.P. | 600 | mg | ||||||
Excipients | q.s. | ||||||||
Approved Colour used | |||||||||
121 | Tablets | Trypsin,Bromelain and Rustoside Trihydrate Tablets
|
Each enteric coated tablet contains : | Self | Approved-26.04.16. | ||||
Trypsin | B.P. | 48 | mg | ||||||
Bromelain | 90 | mg | |||||||
Rustoside Trihydrate | B.P. | 100 | mg | ||||||
Excipients | q.s. | ||||||||
Colour: Yellow Oxide of Iron & Titanium Dioxide | |||||||||
122 | Tablets | Trypsin,Bromelain, Rustoside Trihydrate and Diclofenac Sodium Tablets
|
Each enteric coated tablet contains : | Self | Approved-26.04.16. | ||||
Trypsin | B.P. | 48 | mg | ||||||
Bromelain | 90 | mg | |||||||
Rustoside Trihydrate | B.P. | 100 | mg | ||||||
Diclofenac Sodium | I.P. | 50 | mg | ||||||
Excipients | q.s. | ||||||||
Colour: Yellow Oxide of Iron & Titanium Dioxide |
123 | Tablets | Diclofenac Sodium, Paracetamol and Chlorzoxazone Tablets
(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each film coated tablet contains : | Self | Approved-26.04.16. | |||||
Diclofenac Sodium | B.P. | 50 | mg | |||||||
Paracetamol | I.P. | 325 | mg | |||||||
Chlorzoxazone | USP | 500 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
124 | Tablets | Aceclofenac,Paracetamol and Chlorzoxazone Tablets
(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each film coated tablet contains : | Self | Approved-26.04.16. | |||||
Aceclofenac | I.P. | 100 | mg | |||||||
Paracetamol | I.P. | 325 | mg | |||||||
Chlorzoxazone | U.S.P. | 250 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
125. | Tablets | Telmisartan Tablets I.P. | Each uncoated tablet contains : | Self | Approved-28.04.16. | |||||
Telmisartan | I.P. | 40 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
126. | Tablets | Roxithromycin Tablets I.P. | Each film coated tablet contains : | Self | Approved-28.04.16. | |||||
Roxithromycin | I.P. | 150 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
127. | Capsules | Tramadol Hydrochoride Capsules I.P. | Each hard gelatin capsule contains : | Self | Approved-28.04.16. | |||||
Tramadol Hydrochoride | I.P. | 50 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used in empty capsule shells | ||||||||||
128 | Tablets | Rabeprazole and Domperidone Tablets | Each enteric coated tablet contains : | Self | Approved-28.04.16. | |||||
Rabeprazole Sodium | I.P. | 20 | mg | |||||||
Domperidone | I.P. | 10 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
129. | Tablets | Allopurinol Tablets I.P. | Each uncoated tablet contains : | Self | Approved-28.04.16. | |||||
Allopurinol | I.P. | 100 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
130 | Tablets | Allopurinol Tablets I.P. | Each uncoated tablet contains : | Self | Approved-28.04.16.. | |||||
Allopurinol | I.P. | 300 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
131 | Tablets | Mefenamic Acid and Dicyclomine HCl Tablets | Each uncoated tablet contains : | Self | Approved-28.04.16. | |||||
Mefenamic Acid | I.P. | 250 | mg | |||||||
Dicyclomine Hydrochloride | I.P. | 10 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
132. | Tablets | Diclofenac Potassium, Paracetamol and Serratiopeptidase Tablets
(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each film coated tablet contains : | Self | Approved-28.04.16. | |||||
Diclofenac Potassium | B.P. | 50 | mg | |||||||
Paracetamol | I.P. | 325 | mg | |||||||
Serratiopeptidase
(eq.to enzymatic activity 20,000 units) (as enteric coated granules) |
I.P. | 10 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
133. | Tablets | Aceclofenac,Paracetamol and Serratiopeptidase Tablets
(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each film coated tablet contains : | Self | Approved-28.04.16.
|
|||||
Aceclofenac | I.P. | 100 | mg | |||||||
Paracetamol | I.P. | 325 | mg | |||||||
Serratiopeptidase
(eq.to enzymatic activity 30,000 units) (as enteric coated granules) |
I.P. | 15 | mg | |||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
134 | Liquid Orals | Cyproheptadine Hydrochloride and Tricholine Citrate Syrup | Each 5ml contains : | Self | Approved-02.07.16. | |||||
Cyproheptadine Hydrochloride (anhydrous) | I.P. | 2 | mg | |||||||
Tricholine Citrate (65%) | 275 | mg | ||||||||
Sorbitol Solution 70% (Non-crystallizing) | I.P. | |||||||||
Excipients | q.s. | |||||||||
In a Flavoured Syrupy base | q.s. | |||||||||
Colour: Caramel | I.P. | |||||||||
135 | Liquid Orals | Diastase and Pepsin syrup | Each 15ml contains : | Self | Approved-02.07.16. | |||||||
Diastase (1:1200) | I.P. | 50 | mg | |||||||||
Pepsin (1:3000) | I.P. | 10 | mg | |||||||||
Excipients | q.s. | |||||||||||
Flavoured syrupy base | q.s. | |||||||||||
Colour: Approved colour used | ||||||||||||
136 | Liquid Orals | Diphenhydarmine HCl,Ammonium Chloride,Sodium Citrate and Menthol syrup | Each 5ml (one teaspoonful) contains : | Self | Approved-02.07.16. | |||||||
Diphenhydarmine Hydrochloride | I.P. | 14.08 | mg | |||||||||
Ammonium chloride | I.P. | 138.00 | mg | |||||||||
Sodium Citrate | I.P. | 57.03 | mg | |||||||||
Menthol | I.P. | 1.14 | mg | |||||||||
Excipients | q.s. | |||||||||||
In a flavoured Syrupy base | q.s. | |||||||||||
Colour:Approved colour used | ||||||||||||
137 | Liquid Orals | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup | Each 5ml (one teaspoonful) contains : | Self | Approved-02.07.16. | |||||||
Dextromethrophan Hydrobromide | I.P. | 10 | mg | |||||||||
Chlorpheniramine Maleate | I.P. | 2 | mg | |||||||||
Phenylepherine Hydrochloride | I.P. | 5 | mg | |||||||||
Excipients | q.s. | |||||||||||
In a flavoured syrup base | q.s. | |||||||||||
Colour: Ponceau-4R | ||||||||||||
Dosage:
Adults:10ml,3-4 time a day Children:2-6 years 2.5ml,3-4 time a day 6-12 years 5ml,3-4 time a day |
||||||||||||
138 | Liquid Orals | Montelukast Sodium and Levocetirizine Dihydrochloride Syrup
(For Paediatric Use Only) |
Each 5ml contains : | Self | Approved-02.07.16. | |||||||
Montelukast Sodium
eq.to Montelukast |
I.P. | 4 | mg | |||||||||
Levocetirizine Dihydrochloride | I.P. | 2.5 | mg | |||||||||
Excipients | q.s. | mg | ||||||||||
In a flavoured Syrupy base | q.s. | |||||||||||
Colour: Approved colour used | ||||||||||||
139 | Tablets | Calcium Carbonate and Vitamin D3 Tablets | Each film coated tablet contains : | Self | Approved-02.07.16. | |||||||
Calcium Carbonate
(from Oyster shells) eq.to elemental Calcium |
1250
500 |
mg
mg |
||||||||||
Vitamin D3 | I.P. | 250 | IU | |||||||||
Excipients | q.s. | |||||||||||
Approved colour used | ||||||||||||
140 | Liquid Orals | Vitamin D3 (Cholecalciferol) Drops I.P.
|
Each ml contains : | Self | Approved-02.07.16. | |||||||
Vitamin D3 (Cholecalciferol) | I.P. | 800 | IU | |||||||||
Excipients | q.s. | mg | ||||||||||
In a flavoured Palatable base | q.s. | |||||||||||
Colour: Approved colour used | ||||||||||||
141 | Tablets | Calcium Citrate,Zinc,Vitamin D3 and Magnesium Tablets | Each uncoated tablet contains : | Self | Approved-02.07.16. | |||||||
Calcium Citrate | USP | 1000 | mg | |||||||||
Zinc Sulphate Monohydrate
eq.to elemental Zinc |
I.P. |
4 |
mg |
|||||||||
Vitamin D3 | I.P. | 200 | IU | |||||||||
Magnesium Hydroxide
eq.to elemental Magnesium |
I.P. | 100 | mg | |||||||||
Excipients | q.s. | |||||||||||
Approved colour used | ||||||||||||
142 | Tablets | Calcium Carbonate and Alfacalcidol Tablets | Each film coated tablet contains : | Self | Approved-02.07.16. | |||||||
Calcium Carbonate
(from Oyster shells) eq.to elemental Calcium |
1250
500 |
mg
mg |
||||||||||
Alfacalcidol | I.P. | 0.25 | mcg | |||||||||
Excipients | q.s. | |||||||||||
Approved colour used | ||||||||||||
143 | Tablets | Aceclofenac,Paracetamol and Serratiopeptidase Tablets
(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each film coated tablet contains : | Self | Approved-02.07.16. | |||||||
Aceclofenac | I.P. | 100 | mg | |||||||||
Paracetamol | I.P. | 325 | mg | |||||||||
Serratiopeptidase
(eq.to enzymatic activity 20,000 units) (as enteric coated granules) |
I.P. | 10 | mg | |||||||||
Excipients | q.s. | |||||||||||
Approved Colour used | ||||||||||||
144 | Tablets | Betahistine Hydrochloride Tablets I.P. | Each film coated tablet contains: | Self | Approved-02.07.16. | |||||
Betahistine Hydrochloride | I.P. | 8 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
145 | Tablets | Ofloxacin Tablets I.P. | Each film coated tablet contains: | Self | Approved-02.07.16. | |||||
Ofloxacin | I.P. | 400 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
146 | Tablets | Febuxostat Tablets | Each film coated tablet contains: | Self | Approved-02.07.16. | |||||
Febuxostat | 40 | mg | ||||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
147 | Capsules | Clindamycin Capsule I.P. | Each hard gelatin capsule contains: | Self | Approved-02.07.16. | |||||
Clindamycin Hydrochloride
eq.to Clindamycin |
I.P. | 300 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used empty capsule shells | ||||||||||
148 | Liquid Orals | Lactulose Oral Solution U.S.P. | Each 5ml contains: | Self | Approved-02.07.16. | |||||
Lactulose Conentrate
eq.to Lactulose |
USP | 3.35 | gm | |||||||
In a flavoured syrup base | q.s. | |||||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
149. | Tablets | Pregabalin (SR) and Methylcobalamin Tablets | Each uncoated table contains: | Self | Approved-02.07.16. | |||||
Pregabalin (sustained released) | I.P. | 75 | mg | |||||||
Mecobalamin | J.P. | 1500 | mcg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
Appropriate overages of vitamin added to compensate loss on storage. | ||||||||||
150. | Liquid Orals | Magaldrate and Simethicone Oral Suspension U.S.P. | Each 5ml contains: | Self | Approved-02.07.16. | |||||
Magaldrate (anhydrous) | I.P. | 400 | mg | |||||||
Simethicone | I.P. | 20 | mg | |||||||
Sorbitol Solution 70% (Non-crystallizing) | I.P. | |||||||||
Purified Water | I.P. | q.s. | ||||||||
Excipients | q.s. | |||||||||
Approved Colour used | ||||||||||
Dosage:
Adults and Children over 12 years: 1-2 teaspoonfuls between meals at bed time. Children between 5-12 years: Half the dosage as above or as direct bt the physician.
|
||||||||||
151. | Tablets | Citicoline and Piracetam Tablets | Each film coated tablet contains: | Self | Approved-02.07.16. | |||||
Citicoline Sodium
eq.to Citicoline |
I.P. | 500 | mg | |||||||
Piracetam | I.P. | 800 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
152. | Tablets | Citicoline and Piracetam Tablets | Each film coated tablet contains: | Self | Approved-02.07.16. | |||||
Citicoline Sodium
eq.to Citicoline |
I.P. | 500 | mg | |||||||
Piracetam | I.P. | 400 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
153. | Liquid Orals | Terbutaline Sulphate,Bromhexine Hydrochloride, Guiaphenesin and Menthol Syrup | Each 5ml (one teaspoonful) contains: | Self | Approved-02.07.16. | |||||
Terbutaline Sulphate | I.P. | 1.25 | mg | |||||||
Bromhexine Hydrochloride | I.P. | 4 | mg | |||||||
Guiaphenesin | I.P. | 50 | mg | |||||||
Menthol | I.P. | 1 | mg | |||||||
Excipients | q.s. | |||||||||
In a Pleasantly flavoured syrupy base | q.s. | |||||||||
Approved colour used | ||||||||||
154. | Liquid Orals | Cetirizine Hydrochloride, Phenylephrine Hydrochloride and Paracetamol Syrup | Each 5ml contains: | Self | Approved-02.07.16. | |||||
Cetirizine Hydrochloride | I.P. | 2.5 | mg | |||||||
Phenylephrine Hydrochloride | I.P. | 5 | mg | |||||||
Paracetamol | I.P. | 125 | mg | |||||||
Excipients | q.s. | |||||||||
In a flavoured syrupy base | q.s. | |||||||||
Approved colour used | ||||||||||
155. | Tablets | Glimepride and Metformin
(Sustained Released) Tablets |
Each uncoated tablet contains: | Self | Approved-02.07.16. | ||||
Glimpride | I.P. | 1 | mg | ||||||
Metformin (in sustained release form) | I.P. | 500 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
156. | Tablets | Voglibose Tablets I.P. | Each uncoated tablet contains : | Self | Approved-02.07.16. | ||||
Voglibose | I.P. | 0.2 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
157. | Tablets | Voglibose Tablets I.P. | Each uncoated tablet contains : | Self | Approved-02.07.16. | ||||
Voglibose | I.P. | 0.3 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
158. | Liquid Orals | Sucralfate and Oxetacaine Suspension | Each 10ml contains : | Self | Approved-02.07.16. | ||||
Sucralfate | USP | 1 | gm | ||||||
Oxetacaine | B.P. | 20 | mg | ||||||
Excipients | q.s. | ||||||||
In a flavoured syrupy base | q.s. | ||||||||
Approved colour used | |||||||||
Dosage:10ml.3 to times a day or directed by the physician | |||||||||
159. | Liquid Orals | Lycopene Enriched with Antioxidants, Multivitamin and Multimineral Syrup | Each 10ml contains : | Self | Approved-02.07.16. | ||||
Lycopene 10% | USP | 2000 | mcg | ||||||
Niacinamide | I.P. | 25 | mg | ||||||
Folic Acid | I.P. | 100 | mcg | ||||||
Selenium Dioxide Monohydrate
eq.to Selenium |
B.P. | 35 | mcg | ||||||
Zinc (as Zinc Gluconate USP) | 3 | mg | |||||||
Iodine (as Potassium Iodine IP) | 100 | mcg | |||||||
Copper (as Cupric Sulphate USP) | 500 | mcg | |||||||
Vitamin B12 | I.P. | 1 | mcg | ||||||
Vitamin B6 | I.P. | 1.5 | mg | ||||||
Excipients | q.s. | ||||||||
In a Pleasantly flavoured base | q.s. | ||||||||
Appropriate overages of vitamins added to compensate for any loss on storage | |||||||||
Approved colour used | |||||||||
160. | Tablets | Terbinafine Tablets USP | Each uncoated tablet contains: | Self | Approved-16.07.16. | ||||
Terbinafine Hydrochloride
eq.to Terbinafine
|
USP | 250 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
161. | Liquid Orals | Calcium Carbonate and Vitamin D3 Syrup | Each 5ml contains : | Self | Approved-16.07.16. | ||||
Calcium Carbonate
(Precipitate) eq.to elemental Calcium |
I.P. |
250 |
mg |
||||||
Vitamin D3 | I.P. | 125 | IU | ||||||
Excipients | q.s. | ||||||||
In a flavoured syrupy base | q.s. | ||||||||
Approved colour used | |||||||||
162. | Liquid Orals | Cyproheptadine Hydrochloride and Tricholine Citrate Syrup
(For Veterinary Use Only) |
Each 5ml contains : | Self | Approved-16.07.16. | ||||
Cyproheptadine Hydrochloride (anhydrous) | I.P. | 2 | mg | ||||||
Tricholine Citrate (65%) | 275 | mg | |||||||
Sorbitol Solution 70% (Non-crystallizing) | I.P. | ||||||||
Excipients | q.s. | ||||||||
In a Flavoured Syrupy base | q.s. | ||||||||
Colour: Caramel | I.P. | ||||||||
163. | Tablets | Etizolam Tablets | Each film coated tablet contains : | Self | Approved-16.07.16. | ||||
Etizolam | 0.50 | mg | |||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
164 | Capsules | Itroconazole Capsules | Each hard gelatin capsule contains : | Self | Approved-16.07.16.
|
||||
Itroconazole Pellets
eq.to Itroconazole |
B.P. |
100 |
mg |
||||||
Excipients | q.s. | ||||||||
Empty gelatin capsules contain | |||||||||
165. | Capsules | Itroconazole Capsules | Each hard gelatin capsule contains : | Self | Approved-16.07.16. | ||||
Itroconazole Pellets
eq.to Itroconazole |
B.P. |
200 |
mg |
||||||
Excipients | q.s. | ||||||||
Empty gelatin capsules contain | |||||||||
166. | Liquid Orals | Paracetamol, Cetirizine Hydrochloride, Phenylephrine Hydrochloride, Syrup | Each 5ml contains : | Self |
Approved-16.07.16.
|
||||
Paracetamol | I.P. | 250 | mg | ||||||
Cetirizine Hydrochloride | I.P. | 2.5 | mg | ||||||
Phenylephrine Hydrochloride | I.P. | 2.5 | mg | ||||||
Menthol | I.P. | 1 | mg | ||||||
Excipients | q.s. | ||||||||
In a flavoured syrupy base | q.s. | ||||||||
Approved colour used | |||||||||
167. | Tablets | Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine HCl and Caffeine (anhydrous) Tablets | Each uncoated tablet contains : | Self | Approved-16.07.16. | ||||
Paracetamol | I.P. | 325 | mg | ||||||
Phenylephrine Hydrochloride | I.P. | 5 | mg | ||||||
Diphenhydramine Hydrochloride | I.P. | 25 | mg | ||||||
Caffeine (anhydrous) | I.P. | 30 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
168. | Tablets | Cinnarizine Tablets I.P. | Each film coated tablet contains : | Self | Approved-16.07.16.
|
||||
Cinnarizine | I.P. | 25 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
169. | Tablets | Folic Acid Tablets I.P. | Each uncoated tablet contains : | Self | Approved-16.07.16. | ||||
Folic Acid | I.P. | 5 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
170. | Tablets | Mecobalamin Tablets | Each film coated tablet contains : | Self | Approved-16.07.16. | ||||
Mecobalamin | J.P. | 1500 | mcg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
171. | Tablets | Tranexamic Acid Tablets I.P. | Each film coated tablet contains : | Self | Approved-16.07.16. | ||||
Tranexamic Acid | I.P. | 250 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
172. | Tablets | Tranexamic Acid Tablets I.P. | Each film coated tablet contains : | Self | Approved-16.07.16. | ||||
Tranexamic Acid | I.P. | 500 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
173. | Liquid Orals | Sodium Picosulfate Oral Solution B.P. | Each 5ml (1 teaspoonful approx.)contains : | Self | Approved-16.07.16. | ||||
Sodium Picosulfate | B.P. | 5 | mg | ||||||
Excipients | q.s. | ||||||||
Dosage:As directed by the physician | |||||||||
Approved colour used | |||||||||
174. | Tablets | Etizolam Tablets | Each film coated tablet contains : | Self | Approved-16.07.16. | ||||
Etizolam | 0.25 | mg | |||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
175. | Tablets | Hydroxyzine Tablets I.P. | Each uncoated tablet contains: | Self | Approved-10.08.16. | ||||
Hydroxyzine Hydrochloride | I.P. | 10 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
176. | Tablets | Hydroxyzine Tablets I.P. | Each uncoated tablet contains: | Self | Approved-10.08.16. | ||||
Hydroxyzine Hydrochloride | I.P. | 25 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
177. | Tablets | Olopatadine Hydrochloride Tablets | Each film coated tablet contains: | Self | Approved-10.08.16. | ||||
Olopatadine Hydrochloride | USP | 5 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used | |||||||||
178. | Capsules | Isotretinoin Capsules USP | Each hard gelatin capsule contains: | Self | Approved-10.08.16. | ||||
Isotretinoin | I.P. | 20 | mg | ||||||
Excipients | q.s. | ||||||||
Approved colour used in empty capsule shells | |||||||||
179. | Capsules | Isotretinoin Capsules USP | Each hard gelatin capsule contains: | Self | Approved-10.08.16. | |||||
Isotretinoin | I.P. | 10 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used in empty capsule shells | ||||||||||
180. | Liquid Orals | Pyridoxine Hydrochloride, Nicotinamide, Cyanocobalamin and Lysine Hydrochloride Syrup | Each 10ml contains: | Self | Approved-10.08.16. | |||||
Pyridoxine Hydrochloride | I.P. | 0.75 | mg | |||||||
Nicotinamide | I.P. | 15 | mg | |||||||
Cyanocobalamin | I.P. | 2 | mcg | |||||||
Lysine Hydrochloride | USP | 375 | mg | |||||||
In a flavoured syrupy base | q.s. | |||||||||
Excipients | q.s. | |||||||||
Colour: Approved colour used | ||||||||||
181. | Liquid Orals | Ambroxol Hydrochloride, Levocetirizine Hydrochloride, Guaiphenesin and Menthol Syrup | Each 5ml contains: | Self | Approved-10.08.16. | |||||
Ambroxol Hydrochloride | I.P. | 15 | mg | |||||||
Levocetirizine Hydrochloride | I.P. | 2.5 | mg | |||||||
Guaiphenesin | I.P. | 50 | mg | |||||||
Menthol | I.P. | 1 | mg | |||||||
In a flavoured syrupy base | q.s. | |||||||||
Excipients | q.s. | |||||||||
Colour: Approved colour used | ||||||||||
182. | Tablets | Glimepiride and Metformin Hydrochloride (SR)Tablets | Each uncoated tablet contains: | Self | Approved-10.08.16. | |||||
Glimepiride | I.P. | 2 | mg | |||||||
Metformin Hydrochloride (sustained released) | I.P. | 500 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
183. | Tablets | Glimepiride and Metformin Hydrochloride (SR)Tablets | Each uncoated tablet contains: | Self | Approved-10.08.16. | |||||
Glimepiride | I.P. | 2 | mg | |||||||
Metformin Hydrochloride (sustained released) | I.P. | 1000 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
184. | Tablets | Olmesartan Medoxomil and Hydrochlorothiazide Tablets | Each uncoated tablet contains: | Self | Approved-10.08.16. | |||||
Olmesartan Medoxomil | I.P. | 40 | mg | |||||||
Hydrochlorothiazide | I.P. | 25 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
185. | Tablets | Voglibose and Metformin Hydrochloride Tablets | Each film coated tablet contains : | Self | Approved-10.08.16. | |||||
Voglibose | I.P. | 0.2 | mg | |||||||
Metformin Hydrochloride | I.P. | 500 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
186. | Tablets | Voglibose and Metformin Hydrochloride (SR) Tablets | Each film coated tablet contains : | Self | Approved-10.08.16. | |||||
Voglibose | I.P. | 0.3 | mg | |||||||
Metformin Hydrochloride
(sustained Released) |
I.P. | 500 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
187. | Tablets | Amlodipine Besilate and Atenolol Tablets | Each uncoated tablet contains: | Self | Approved-10.08.16. | |||||
Amlodipine Besilate
eq.to Amlodipine |
I.P. | 5 | mg | |||||||
Atenolol | I.P. | 50 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
188. | Tablets | Citicoline Tablets | Each film coated tablet contains: | Self | Approved-10.08.16. | |||||
Citicoline Sodium
eq.to Citicoline |
I.P. | 500 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
189. | Tablets | Losartan Potassium and Hydrochlorothiazide Tablets I.P. | Each film coated tablet contains: | Self | Approved-10.08.16. | |||||
Losartan Potassium | I.P. | 50 | mg | |||||||
Hydrochlorothiazide | I.P. | 12.5 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
190. | Tablets | Loratadine Tablets USP | Each uncoated tablet contains: | Self | Approved-10.08.16.
|
|||||
Loratadine | USP | 10 | mg | |||||||
Excipients | q.s. | |||||||||
Approved colour used | ||||||||||
191 | Tablets | Rosuvastatin Calcium Tablets I.P. | Each film coated tablet contains: | Self | Approved-27.10.16.
|
|||
Rosuvastatin Calcium
eq.to Rosuvastatin |
I.P. | 5 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
192 | Tablets | Rosuvastatin Calcium Tablets I.P. | Each film coated tablet contains: | Self | Approved-27.10.16.
|
|||
Rosuvastatin Calcium
eq.to Rosuvastatin |
I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
193 | Tablets | Telmisartan and Hydrochlorothiazide Tablets U.S.P. | Each film coated tablet contains: | Self | Approved-27.10.16.
|
|||
Telmisartan | I.P. | 40 | mg | |||||
Hydrochlorothiazide | I.P. | 12.5 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
194 | Tablets | Telmisartan and Hydrochlorothiazide Tablets U.S.P. | Each film coated tablet contains: | Self | Approved-27.10.16.
|
|||
Telmisartan | I.P. | 80 | mg | |||||
Hydrochlorothiazide | I.P. | 12.5 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
195 | Tablets | Metformin Hydrochloride Sustained Released Tablets I.P. | Each uncoated tablet contains: | Self | Approved-27.10.16.
|
|||
Metformin Hydrochloride
(sustained released) |
I.P. | 500 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
196 | Tablets | Duloxetine Hydrochloride Tablets | Each film coated tablet contains: | Self | Approved-27.10.16.
|
|||
Duloxetine Hydrochloride
eq.to Duloxetine |
USP | 30 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
197 | Tablets | Amlodipine Besilate Tablets I.P. | Each film coated tablet contains: | Self | Approved-27.10.16.
|
|||
Amlodipine Besilate
eq.to Amlodipine |
I.P. | 5 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
198 | Capsules | Esomperazole (EC) and Itopride (SR) Hydrochloride Capsules | Each hard gelatin capsule contains: | Self | Approved-27.10.16.
|
|||
Esomperazole Magnesium Trihydrate
eq.to Esomperazole (as enteric coated pellets) |
I.P. |
40 |
mg |
|||||
Itopride Hydrochloride
(as sustained released pellets) |
150 | mg | ||||||
Excipients | q.s. | |||||||
Approved colour used in empty capsule shells |
199 | Liquid Orals | Paracetamol, Cetirizine Hydrochloride, Phenylephrine Hydrochloride and Menthol Suspension | Each 5ml contains : | Self | Approved-27.10.16.
|
||||||
Paracetamol | I.P. | 250 | mg | ||||||||
Cetirizine Hydrochloride | I.P. | 2.5 | mg | ||||||||
Phenylephrine Hydrochloride | I.P. | 2.5 | mg | ||||||||
Menthol | I.P. | 1 | mg | ||||||||
Excipients | q.s. | ||||||||||
In a flavoured syrupy base | q.s. | ||||||||||
Approved colour used | |||||||||||
200 | Tablets | Levosulpride Tablets | Each film coated tablet contains: | Self | Approved-27.10.16.
|
||||||
Levosulpride | 50 | mg | |||||||||
Excipients | q.s. | ||||||||||
Approved Colour used | |||||||||||
201 | Tablets | Dexthromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets | Each 5ml contains: | Self | Approved-27.10.16.
|
||||||
Dexthromethorphan Hydrobromide | I.P. | 10 | mg | ||||||||
Chlorpheniramine Maleate | I.P. | 2 | mg | ||||||||
Excipients | q.s. | ||||||||||
In a flavoured syrupy base | q.s. | ||||||||||
Approved Colour used | |||||||||||
202 | Tablets | Diclofenac Potassium and Serratiopeptidase Tablets | Each enteric coated tablet contains: | Self | Approved-27.10.16.
|
|||
Diclofenac Potassium | B.P. | 50 | mg | |||||
Serratiopeptidase
(eq.to enzymatic activity 20,000units) |
I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
203 | Tablets | Escitalopram Tablets I.P. | Each film coated tablet contains: | Self | Approved-03.12.16.
|
|||
Escitalopram Oxalate
eq.to Escitalopram |
I.P. | 5 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
204 | Tablets | Escitalopram Tablets I.P. | Each film coated tablet contains: | Self | Approved-03.12.16.
|
|||
Escitalopram Oxalate
eq.to Escitalopram |
I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
205 | Tablets | Eperisone Hydrochloride Tablets | Each film coated tablet contains: | Self | Approved-03.12.16.
|
|||
Eperisone Hydrochloride | 50 | mg | ||||||
Excipients | q.s. | |||||||
Approved Colour used |
206 | Tablets | Eperisone Hydrochloride and Paracetamol Tablets | Each film coated tablet contains: | Self | Approved-03.12.16.
|
|||
Eperisone Hydrochloride | 50 | mg | ||||||
Paracetamol | I.P. | 325 | mg | |||||
Excipients | ||||||||
Approved Colour used |
207 | Tablets | Linezolid Tablets I.P. | Each film coated tablet contains: | Self | Approved-03.12.16.
|
|||
Linezolid | I.P. | 600 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
208 | Tablets | Folic Acid Tablets I.P. | Each film coated tablet contains: | Self | Approved-03.12.16.
|
|||
Folic Acid | I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |
209 | Tablets | Diclofenac Potassium Paracetamol and Chlorzoxazone Tablets
(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
Each film coated tablets contains : | Self | Approved-03.12.16.
|
|||
Diclofenac Potassium | B.P. | 50 | mg | |||||
Paracetamol | I.P. | 325 | mg | |||||
Chlorzoxazone | USP | 250 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used |
210 | Liquid Orals | Montelukast Sodium and Levocetirizine Dihydrochloride Suspension
(For Paediatric Use Only) |
Each 5ml contains : | Self | Approved-03.12.16.
|
|||
Montelukast Sodium
eq.to Montelukast |
I.P. | 4 | mg | |||||
Levocetirizine Dihydrochloride | I.P. | 2.5 | mg | |||||
Excipients | q.s. | mg | ||||||
In a flavoured Syrupy base | q.s. | |||||||
Colour: Approved colour used |
211 | Capsules | Rabeprazole Sodium(EC) and Aceclofenac(SR) Capsules | Each hard gelatin capsule contains: | Self | Approved-03.12.16.
|
|||
Rabeprazole Sodium
(as enteric coated pellets) |
I.P. | 20 | mg | |||||
Aceclofenac
(as sustained release pellets) |
I.P. | 200 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used in empty capsule shells |
212 | Tablets | Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine HCl and Caffeine (anhydrous) Tablets | Each uncoated tablet contains : | Self | Approved-03.12.16.
|
|||
Paracetamol | I.P. | 325 | mg | |||||
Phenylephrine Hydrochloride | I.P. | 5 | mg | |||||
Diphenhydramine Hydrochloride | I.P. | 25 | mg | |||||
Caffeine (anhydrous) | I.P. | 30 | mg | |||||
Excipients | q.s. | |||||||
Approved colour used |
213 | Liquid Orals | Ofloxacin, Metronidazole Benzoate and Simethicone Suspension
(For Paediatric Use) |
Each 5ml contains: | Self | Approved-03.12.16.
|
|||
Ofloxacin | I.P. | 50 | mg | |||||
Metronidazole Benzoate
eq.to Metronidazole |
I.P. | 120 | mg | |||||
Simethicone | I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
In a flavoured syrupy base | q.s. | |||||||
Approved Colour used |
214
|
Tablets | Paracetamol, Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablets | Each film coated tablet contains: | Self | Approved-03.12.16.
|
|||
Paracetamol | I.P. | 325 | mg | |||||
Cetirizine Hydrochloride | I.P. | 5 | mg | |||||
Phenylephrine Hydrochloride | I.P. | 10 | mg | |||||
Excipients | q.s. | |||||||
Approved Colour used |